AVITA Medical: New Products, Same Old Cash Burn (Rating Downgrade) [Seeking Alpha]
Avita Medical, Inc. (RCEL)
Company Research
Source: Seeking Alpha
RECELL GO's launch increased SG&A expenses, contributing to AVITA Medical, Inc.'s higher net losses in Q2 2024. Despite lowering its 2024 revenue guidance, AVITA Medical still anticipates significant year-over-year growth of 37-41%. AVITA Medical's cash runway is approximately nine months, with $54.1 million in cash and securities available as of June 30, 2024. Adoption barriers for RECELL technology persist, although RECELL GO aims to reduce training and procedural complexities. I recommend selling AVITA Medical stock due to persistent financial pressures and challenges in achieving significant market adoption. D-Keine Introduction AVITA Medical, Inc. NASDAQ: RCEL ) stock is down 47% since my last look in March. The title said it all: “Unconvincing Growth Amid Fierce Competition In The Burn Care Sector.” My recommendation was hold, citing “unresolved concerns over S&M spending efficiency and competitive advantage.” The company subsequently has released two earnings rep
Show less
Read more
Impact Snapshot
Event Time:
RCEL
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RCEL alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RCEL alerts
High impacting Avita Medical, Inc. news events
Weekly update
A roundup of the hottest topics
RCEL
News
- AVITA Medical to Present at TD Cowen’s 45?? Annual Health Care ConferenceGlobeNewswire
- High Growth Tech Stocks To Watch In February 2025 [Yahoo! Finance]Yahoo! Finance
- AVITA Medical, Inc. (NASDAQ: RCEL) had its price target lowered by analysts at D. Boral Capital from $25.00 to $22.00. They now have a "buy" rating on the stock.MarketBeat
- Exploring High Growth Tech Stocks Including Lime Technologies And Two Others [Yahoo! Finance]Yahoo! Finance
- Exploring None High Growth Tech Stocks with Promising Potential [Yahoo! Finance]Yahoo! Finance
RCEL
Earnings
- 2/13/25 - Miss
RCEL
Sec Filings
- 3/10/25 - Form 4
- 2/20/25 - Form 4
- 2/20/25 - Form 4
- RCEL's page on the SEC website